Rhythm Pharmaceuticals (RYTM) Debt to Equity (2016 - 2025)
Historic Debt to Equity for Rhythm Pharmaceuticals (RYTM) over the last 5 years, with Q3 2025 value amounting to $0.73.
- Rhythm Pharmaceuticals' Debt to Equity changed N/A to $0.73 in Q3 2025 from the same period last year, while for Sep 2025 it was $0.73, marking a year-over-year change of. This contributed to the annual value of $5.05 for FY2024, which is 70824.61% up from last year.
- According to the latest figures from Q3 2025, Rhythm Pharmaceuticals' Debt to Equity is $0.73.
- In the past 5 years, Rhythm Pharmaceuticals' Debt to Equity ranged from a high of $5.78 in Q1 2025 and a low of -$9.22 during Q2 2025
- In the last 3 years, Rhythm Pharmaceuticals' Debt to Equity had a median value of $0.73 in 2025 and averaged $0.59.
- Over the last 5 years, Rhythm Pharmaceuticals' Debt to Equity had its largest YoY gain of 70824.61% in 2024, and its largest YoY loss of 70824.61% in 2024.
- Rhythm Pharmaceuticals' Debt to Equity (Quarter) stood at $0.63 in 2023, then soared by 708.25% to $5.05 in 2024, then plummeted by 85.51% to $0.73 in 2025.
- Its Debt to Equity was $0.73 in Q3 2025, compared to -$9.22 in Q2 2025 and $5.78 in Q1 2025.